SEPTInvestingStart Free

PDSB SCHEDULE 13D/A: Board change

Filed with the SEC on · accession 0001193125-26-456632

PDSB filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 12, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -1.5% by the first close after the filing.

Summary of the filing

Nant Capital exercised all 17,699,115 common warrants of PDS Biotechnology for $3.89 million, increasing its beneficial ownership to 19.9%, and its sole member Patrick Soon-Shiong was appointed to the board of directors.

For details, click here →

Key details

Aggregate exercise price of common warrants$3.9M
Milestone closing subscription amount$10.0M
Reporting person / major shareholderNant Capital, LLC
IssuerPDS Biotechnology Corporation
Affiliate of reporting personNantWorks, LLC
Sole member of nant capital, llcPatrick Soon-Shiong
Senior vice president finance, corporate strategy of nantworks, llcJames Banaag

How PDSB stock reacted

Close before

$1.02

Nov 11, 2026

First close after

-1.47%

$1.00

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PDSB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PDSB?

Click here

Frequently asked questions

What did PDSB file with the SEC on Nov 12, 2026?

PDSB filed a SCHEDULE 13D/A (Board change). Nant Capital exercised all 17,699,115 common warrants of PDS Biotechnology for $3.89 million, increasing its beneficial ownership to 19.9%, and its sole member Patrick Soon-Shiong was appointed to the board of directors.

What does a board change mean for PDSB stock?

Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

How did PDSB stock react to this filing?

PDSB closed at $1.02 before the filing and $1.00 on Nov 12, 2026 (-1.47%).

Other PDSB SEC filings

Get alerts when PDSB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
PDSB overviewPDSB analysisPDSB newsLatest SEC filings